IMAX’s (IMAX) “Outperform” Rating Reaffirmed at Wedbush

Wedbush reissued their outperform rating on shares of IMAX (NYSE:IMAX – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $22.00 price target on the stock. Wedbush also issued estimates for IMAX’s Q2 2024 earnings at $0.12 EPS, Q3 2024 earnings at $0.30 EPS, Q1 2025 earnings at […]

Leave a Reply

Your email address will not be published.

Previous post Nicolet Bankshares (NYSE:NIC) Price Target Increased to $86.00 by Analysts at Keefe, Bruyette & Woods
Next post ConocoPhillips (NYSE:COP) Price Target Raised to $157.00